CCR5 blockade in combination with cyclosporine increased cardiac graft survival and generated alternatively activated macrophages in primates

Journal of Immunology

Volumn 186, Issue 6, 2011, Pages 3753-3761

  Li, Jun ^a   Chen, Gang ^a   Ye, Ping ^a   Wang, Sihua ^a   Zhang, Kailun ^a   Chen, Wenhao ^b   Stepkowski, Stanislaw M ^b   Li, Junhua ^a   Zhong, Shan ^a   Xia, Jiahong ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD68 ANTIGEN; CD8 ANTIGEN; CHEMOKINE RECEPTOR CCR5; CYCLOSPORIN A; MARAVIROC; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; GRAFT SURVIVAL; HEART GRAFT; IN VIVO STUDY; LYMPHOCYTIC INFILTRATION; MACROPHAGE ACTIVATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHESUS MONKEY; UPREGULATION;

ANIMALS; BINDING, COMPETITIVE; CELL DIFFERENTIATION; CELLS, CULTURED; COCULTURE TECHNIQUES; CYCLOHEXANES; CYCLOSPORINE; DRUG THERAPY, COMBINATION; GRAFT SURVIVAL; HEART TRANSPLANTATION; LYMPHOCYTE CULTURE TEST, MIXED; MACACA MULATTA; MACROPHAGE ACTIVATION; MACROPHAGES; MALE; PPAR GAMMA; PROTEIN BINDING; RECEPTORS, CCR5; TRIAZOLES; UP-REGULATION;

EID: 79953210368     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1002143     Document Type: Article

References (50)

1. Springer, T. A. 1995. Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration. Annu. Rev. Physiol. 57: 827-872.
2. Flach, R., N. Speidel, S. Flohé, J. Börgermann, I. G. Dresen, J. Erhard, and F. U. Schade. 1998. Analysis of intragraft cytokine expression during early reperfusion after liver transplantation using semi-quantitative RT-PCR. Cytokine 10: 445-451.
3. H2 polarization by the chemokine monocyte chemoattractant protein-1. Nature 404: 407-411.
4. Murphy, P. M., M. Baggiolini, I. F. Charo, C. A. Hébert, R. Horuk, K. Matsushima, L. H. Miller, J. J. Oppenheim, and C. A. Power. 2000. International union of pharmacology, XXII: Nomenclature for chemokine receptors. Pharmacol. Rev. 52: 145-176.
5. Luster, A. D. 1998. Chemokines: chemotactic cytokines that mediate inflammation. N. Engl. J. Med. 338: 436-445.
6. Schmauss, D., and M. Weis. 2008. Cardiac allograft vasculopathy: recent developments. Circulation 117: 2131-2141. (Pubitemid 351596195)
7. Jun, L., Z. Kailun, X. Aini, X. Lei, W. Guohua, W. Sihua, Y. Ping, S. Tucheng, J. Xionggang, C. Wenwei, and X. Jiahong. 2010. Combined treatment with chemokine receptor 5 blocker and cyclosporine induces prolonged graft survival in a mouse model of cardiac transplantation. J. Heart Lung Transplant. 29: 461-470.
8. Li, J., K. Zhang, P. Ye, S. Wang, and J. Xia. 2009. CCR5 blockade in combination with rapamycin prolongs cardiac allograft survival in mice. Clin. Exp. Immunol. 157: 437-445.
9. Li, J., J. Xia, K. Zhang, and L. Xu. 2009. Suppression of acute and chronic cardiac allograft rejection in mice by inhibition of chemokine receptor 5 in combination with cyclosporine A. J. Surg. Res. 157: 81-90.
10. Schröder, C., R. N. Pierson, III, B. N. Nguyen, D. W. Kawka, L. B. Peterson, G. Wu, T. Zhang, M. S. Springer, S. J. Siciliano, S. Iliff, et al. 2007. CCR5 blockade modulates inflammation and alloimmunity in primates. J. Immunol. 179: 2289-2299.
11. Dehmel, S., S. Wang, C. Schmidt, E. Kiss, R. P. Loewe, S. Chilla, D. Schlöndorff, H. J. Gröne, and B. Luckow. 2010. Chemokine receptor Ccr5 deficiency induces alternative macrophage activation and improves long-term renal allograft outcome. Eur. J. Immunol. 40: 267-278.
12. Kirk, A. D., L. C. Burkly, D. S. Batty, R. E. Baumgartner, J. D. Berning, K. Buchanan, J. H. Fechner, Jr., R. L. Germond, R. L. Kampen, N. B. Patterson, et al. 1999. Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates. Nat. Med. 5: 686-693.
13. Preston, E. H., H. Xu, K. K. Dhanireddy, J. P. Pearl, F. V. Leopardi, M. F. Starost, D. A. Hale, and A. D. Kirk. 2005. IDEC-131 (anti-CD154), sirolimus and donor-specific transfusion facilitate operational tolerance in non-human primates. Am. J. Transplant. 5: 1032-1041.
14. Suzuki, J., M. Isobe, M. Kawauchi, M. Endoh, J. Amano, and S. Takamoto. 2000. Altered expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in acutely rejected myocardium and coronary arteriosclerosis in cardiac allografts of nonhuman primates. Transpl. Int. 13: 106-113.
15. Wright, H. M., C. B. Clish, T. Mikami, S. Hauser, K. Yanagi, R. Hiramatsu, C. N. Serhan, and B. M. Spiegelman. 2000. A synthetic antagonist for the peroxisome proliferator-activated receptor gamma inhibits adipocyte differentiation. J. Biol. Chem. 275: 1873-1877.
16. Hsu, S. M., L. Raine, and H. Fanger. 1981. Use of avidin-biotin- peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J. Histochem. Cytochem. 29: 577-580.
17. Schnickel, G. T., S. Bastani, G. R. Hsieh, A. Shefizadeh, R. Bhatia, M. C. Fishbein, J. Belperio, and A. Ardehali. 2008. Combined CXCR3/CCR5 blockade attenuates acute and chronic rejection. J. Immunol. 180: 4714-4721.
18. Crowe, J. E., Jr., E. C. Sannella, S. Pfeiffer, G. L. Zorn, A. Azimzadeh, R. Newman, G. G. Miller, and R. N. Pierson. 2003. CD154 regulates primate humoral immunity to influenza. Am. J. Transplant. 3: 680-688.
19. Gordon, S., and P. R. Taylor. 2005. Monocyte and macrophage heterogeneity. Nat. Rev. Immunol. 5: 953-964.
20. Stout, R. D., C. Jiang, B. Matta, I. Tietzel, S. K. Watkins, and J. Suttles. 2005. Macrophages sequentially change their functional phenotype in response to changes in microenvironmental influences. J. Immunol. 175: 342-349. (Pubitemid 40884337)
21. Martinez, F. O., L. Helming, and S. Gordon. 2009. Alternative activation of macrophages: an immunologic functional perspective. Annu. Rev. Immunol. 27: 451-483.
22. Clark, R. B., D. Bishop-Bailey, T. Estrada-Hernandez, T. Hla, L. Puddington, and S. J. Padula. 2000. The nuclear receptor PPARg and immunoregulation: PPARg mediates inhibition of helper T cell responses. J. Immunol. 164: 1364-1371.
23. Gosset, P., A. S. Charbonnier, P. Delerive, J. Fontaine, B. Staels, J. Pestel, A. B. Tonnel, and F. Trottein. 2001. Peroxisome proliferator-activated receptor γ activators affect the maturation of human monocyte-derived dendritic cells. Eur. J. Immunol. 31: 2857-2865.
24. Nencioni, A., F. Grünebach, A. Zobywlaski, C. Denzlinger, W. Brugger, and P. Brossart. 2002. Dendritic cell immunogenicity is regulated by peroxisome proliferator-activated receptor gamma. J. Immunol. 169: 1228-1235. (Pubitemid 34809163)
25. + T cell anergy. J. Immunol. 178: 2122-2131.
26. Goerdt, S., and C. E. Orfanos. 1999. Other functions, other genes: alternative activation of antigen-presenting cells. Immunity 10: 137-142.
27. Odegaard, J. I., R. R. Ricardo-Gonzalez, M. H. Goforth, C. R. Morel, V. Subramanian, L. Mukundan, A. Red Eagle, D. Vats, F. Brombacher, A. W. Ferrante, and A. Chawla. 2007. Macrophage-specific PPARγ controls alternative activation and improves insulin resistance. Nature 447: 1116-1120. (Pubitemid 47014427)
28. Coste, A., M. Dubourdeau, M. D. Linas, S. Cassaing, J. C. Lepert, P. Balard, S. Chalmeton, J. Bernad, C. Orfila, J. P. Séguéla, and B. Pipy. 2003. PPARg promotes mannose receptor gene expression in murine macrophages and contributes to the induction of this receptor by IL-13. Immunity 19: 329-339. (Pubitemid 37153410)
29. Coste, A., C. Lagane, C. Filipe, H. Authier, A. Galès, J. Bernad, V. Douin- Echinard, J. C. Lepert, P. Balard, M. D. Linas, et al. 2008. IL-13 attenuates gastrointestinal candidiasis in normal and immunodeficient RAG-22/2 mice via peroxisome proliferator-activated receptor-g activation. J. Immunol. 180: 4939-4947.
30. Tontonoz, P., L. Nagy, J. G. Alvarez, V. A. Thomazy, and R. M. Evans. 1998. PPARγ promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell 93: 241-252.
31. Berry, A., P. Balard, A. Coste, D. Olagnier, C. Lagane, H. Authier, F. Benoit- Vical, J. C. Lepert, J. P. Séguéla, J. F. Magnaval, et al. 2007. IL-13 induces expression of CD36 in human monocytes through PPARγ activation. Eur. J. Immunol. 37: 1642-1652.
32. Huang, J. T., J. S. Welch, M. Ricote, C. J. Binder, T. M. Willson, C. Kelly, J. L. Witztum, C. D. Funk, D. Conrad, and C. K. Glass. 1999. Interleukin-4- dependent production of PPAR-γ ligands in macrophages by 12/15-lipoxygenase. Nature 400: 378-382.
33. Nagy, L., P. Tontonoz, J. G. Alvarez, H. Chen, and R. M. Evans. 1998. Oxidized LDL regulates macrophage gene expression through ligand activation of PPARγ. Cell 93: 229-240.
34. -/- recipients. Am. J. Transplant. 8: 557-566.
35. Nozaki, T., H. Amano, A. Bickerstaff, C. G. Orosz, A. C. Novick, K. Tanabe, and R. L. Fairchild. 2007. Antibody-mediated rejection of cardiac allografts in CCR5-deficient recipients. J. Immunol. 179: 5238-5245.
36. Amano, H., A. Bickerstaff, C. G. Orosz, A. C. Novick, H. Toma, and R. L. Fairchild. 2005. Absence of recipient CCR5 promotes early and increased allospecific antibody responses to cardiac allografts. J. Immunol. 174: 6499-6508.
37. Yi, T., Y. Chen, L. Wang, G. Du, D. Huang, D. Zhao, H. Johnston, J. Young, I. Todorov, D. T. Umetsu, et al. 2009. Reciprocal differentiation and tissue-specific pathogenesis of Th1, Th2, and Th17 cells in graft-versus-host disease. Blood 114: 3101-3112.
38. Saiura, A., C. Mataki, T. Murakami, M. Umetani, Y. Wada, T. Kohro, H. Aburatani, Y. Harihara, T. Hamakubo, T. Yamaguchi, et al. 2001. A comparison of gene expression in murine cardiac allografts and isografts by means DNA microarray analysis. Transplantation 72: 320-329. (Pubitemid 32729356)
39. Koh, K. P., Y. Wang, T. Yi, S. L. Shiao, M. I. Lorber, W. C. Sessa, G. Tellides, and J. S. Pober. 2004. T cell-mediated vascular dysfunction of human allografts results from IFN-γ dysregulation of NO synthase. J. Clin. Invest. 114: 846-856.
40. Wood, K. J., and S. Sakaguchi. 2003. Regulatory T cells in transplantation tolerance. Nat. Rev. Immunol. 3: 199-210.
41. + Th17 mediate costimulation blockade-resistant allograft rejection in T-betdeficient mice. J. Immunol. 181: 3906-3914.
42. Yates, S. F., A. M. Paterson, K. F. Nolan, S. P. Cobbold, N. J. Saunders, H. Waldmann, and P. J. Fairchild. 2007. Induction of regulatory T cells and dominant tolerance by dendritic cells incapable of full activation. J. Immunol. 179: 967-976.
43. Geijtenbeek, T. B., S. J. van Vliet, A. Engering, B. A. 't Hart, and Y. van Kooyk. 2004. Self- and nonself-recognition by C-type lectins on dendritic cells. Annu. Rev. Immunol. 22: 33-54.
44. Magil, A. B. 2009. Monocytes/macrophages in renal allograft rejection. Transplant. Rev. (Orlando) 23: 199-208.
45. Taylor, P. R., L. Martinez-Pomares, M. Stacey, H. H. Lin, G. D. Brown, and S. Gordon. 2005. Macrophage receptors and immune recognition. Annu. Rev. Immunol. 23: 901-944.
46. Wyburn, K. R., M. D. Jose, H. Wu, R. C. Atkins, and S. J. Chadban. 2005. The role of macrophages in allograft rejection. Transplantation 80: 1641-1647.
47. H2 paradigm. Nat. Rev. Immunol. 4: 583-594.
48. Bouhlel, M. A., B. Derudas, E. Rigamonti, R. Dièvart, J. Brozek, S. Haulon, C. Zawadzki, B. Jude, G. Torpier, N. Marx, et al. 2007. PPARg activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties. Cell Metab. 6: 137-143. (Pubitemid 47189091)
49. Wang, Y., Y. P. Wang, G. Zheng, V. W. Lee, L. Ouyang, D. H. Chang, D. Mahajan, J. Coombs, Y. M. Wang, S. I. Alexander, and D. C. Harris. 2007. Ex vivo programmed macrophages ameliorate experimental chronic inflammatory renal disease. Kidney Int. 72: 290-299.
50. Tzachanis, D., A. Berezovskaya, L. M. Nadler, and V. A. Boussiotis. 2002. Blockade of B7/CD28 in mixed lymphocyte reaction cultures results in the generation of alternatively activated macrophages, which suppress T-cell responses. Blood 99: 1465-1473.